אללייזו ישראל - עברית - Ministry of Health

אללייזו

pfizer pharmaceuticals israel ltd - taliglucerase alfa - אבקה להכנת תמיסה לאינפוזיה - taliglucerase alfa 200 u/vial - taliglucerase alfa - taliglucerase alfa - elelyso (taliglucerase alfa ) for injection is a hydrolytic lysosomal glucocerebroside - specific enzyme indicated for long - term enzyme replacement therapy (ert) for adults with a confirmed diagnosis of type 1 gaucher disease.

סרזיים 400 יחידות ישראל - עברית - Ministry of Health

סרזיים 400 יחידות

sanofi israel ltd - imiglucerase - אבקה להכנת תמיסה מרוכזת לעירוי - imiglucerase 400 u/vial - imiglucerase - imiglucerase - for the long term enzyme replacement therapy for patients with a confirmed diagnosis of type 1 gaucher disease that results in one or more of the following conditions: - anemia - thrombocytopenia - bone disease - hepatomegaly or splenomegaly.

ויפריב 400 ישראל - עברית - Ministry of Health

ויפריב 400

takeda israel ltd - velaglucerase alfa - lyophilized powder for infusion - velaglucerase alfa 400 u/vial - velaglucerase alfa - velaglucerase alfa - vpriv is a hydrolytic glucocerebroside – specific enzyme indicated for the long term replacement therapy (ert) for pediatric and adult patients with type 1 gaucher disease.

ברינרט ישראל - עברית - Ministry of Health

ברינרט

csl behring ltd., israel - c - 1 esterase inhibitor human - אבקה להמסה להזרקה\אינפוזיה - c - 1 esterase inhibitor human 500 iu/vial - c1- inhibitor,plasma derived - c1- inhibitor,plasma derived - hereditary angioedema type i and ii (hea) , treatment of acute episodes.

סרזים 200 יחידות ישראל - עברית - Ministry of Health

סרזים 200 יחידות

sanofi - aventis israel ltd - imiglucerase 200 u/vial - powder for solution for infusion - imiglucerase - for the long term enzyme replacement therapy for patients with a confirmed diagnosis of type 1 gaucher disease that results in one or more of the following conditions: - anemia , - thrombocytopenia , - bone disease , - hepatomegaly or splenomegaly.

PhaSeal ישראל - עברית - Ministry of Health

phaseal

ביו מד פארמה בע"מ - אחר - ערכה סגורה להכנה ומתן ציטוטוקסיקה

הגרדה 2000 IU ישראל - עברית - Ministry of Health

הגרדה 2000 iu

csl behring ltd., israel - c - 1 esterase inhibitor human - אבקה וממס להכנת תמיסה להזרקה - c - 1 esterase inhibitor human 2000 iu/vial - c1- inhibitor,plasma derived

הגרדה 3000 IU ישראל - עברית - Ministry of Health

הגרדה 3000 iu

csl behring ltd., israel - c - 1 esterase inhibitor human - אבקה וממס להכנת תמיסה להזרקה - c - 1 esterase inhibitor human 3000 iu/vial - c1- inhibitor,plasma derived

גנוטרופין 5.3 מג ישראל - עברית - Ministry of Health

גנוטרופין 5.3 מג

pfizer pharmaceuticals israel ltd - somatropin - אבקה להכנת תמיסה לזריקה - somatropin 5.3 mg - somatropin - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (height sds<2.5 and parenteral adjusted height sds < -1) in short children born sga (sga - small for gestational age i.e. born small in relation to the length of the fetus development) with a birth weight and/or length < 2 sd who failed to show catch up growth (hv sds < 0 during the last year) by 4 years of age or later. prader willi syndrome for improvement of growth and body composition. adults: for adults who have suffered from growth-hormone deficiency since childhood. for adults who have aquired growth hormone deficiency due to a pituitary pathology causing hypopituitarism.